23

PowerPoint · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing

  • Upload
    dohuong

  • View
    217

  • Download
    4

Embed Size (px)

Citation preview

Page 1: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 2: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 3: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 4: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 5: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 6: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 7: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 8: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 9: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 10: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 11: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 12: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 13: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 14: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 15: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 16: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 17: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 18: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 19: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 20: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 21: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 22: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing
Page 23: PowerPoint  · PDF fileThe information in this presentation is current as of this date. ... R428/BGB324 - Oral Axl Inhibitor for Oncology (BerGenBio) Phase 1 Ongoing